Saxenda is administered as a once-daily subcutaneous injection with a dose titration schedule starting at 0.6 mg and increasing weekly to the maintenance dose of 3.0 mg
By engaging GIP, GLP-1, and glucagon receptors, Terzepatide can reduce food intake, enhance safety, and improve insulin sensitivity, making it a promising candidate for obesity management
The general value proposition is straightforward: a compounded GLP-1 at a lower monthly cost than brand-name Wegovy, Ozempic, Mounjaro, or Zepbound, shipped cold-chain to most US states after an asynchronous telehealth consult
Says Kirti Ganorkar, MD Sun Pharma: "With lifestyle diseases on the rise, there is a growing need for holistic, patient-centric solutions
For example, it is not yet fully understood how incretin receptor agonists achieve their effect on body weight
Sensing that they were on to something huge, researchers doubled down and the pharmacology rapidly evolved